Abstract
The therapeutic use of tyrosine kinase inhibitors (TKIs) represents one of the successful strategies for the treatment of glioblastoma (GBM). Pyrazolo[3,4-d]pyrimidines have already been reported as promising small molecules active as c-Src/Abl dual inhibitors. Herein, we present a series of pyrazolo[3,4-d]pyrimidine derivatives, selected from our in-house library, to identify a promising candidate active against GBM. The inhibitory activity against c-Src and Abl was investigated, and the antiproliferative profile against four GBM cell lines was studied. For the most active compounds endowed with antiproliferative efficacy in the low-micromolar range, the effects toward nontumoral, healthy cell lines (fibroblasts FIBRO 2-93 and keratinocytes HaCaT) was investigated. Lastly, the in silico and in vitro ADME properties of all compounds were also assessed. Among the tested compounds, the promising inhibitory activity against c-Src and Abl (Ki 3.14 µM and 0.44 µM, respectively), the irreversible, apoptotic-mediated death toward U-87, LN18, LN229, and DBTRG GBM cell lines (IC50 6.8 µM, 10.8 µM, 6.9 µM, and 8.5 µM, respectively), the significant reduction in GBM cell migration, the safe profile toward FIBRO 2-93 and HaCaT healthy cell lines (CC50 91.7 µM and 126.5 µM, respectively), the high metabolic stability, and the excellent passive permeability across gastrointestinal and blood–brain barriers led us to select compound 5 for further in vivo assays.
Funding Information
  • Regione Toscana (TUSCAVIR.NET Bando Ricerca Salute 2018 B64I18013740002, Grant IG-2019, project code 23725, Grant IG-2017, project code 20762, Grant IG-2020, project code 24448, PRIN 2017 2017SA5837_004)
  • the AIRC Foundation for Cancer Research in Italy (Fondazione AIRC per la Ricerca sul Cancro, AIRC) (TUSCAVIR.NET Bando Ricerca Salute 2018 B64I18013740002, Grant IG-2019, project code 23725, Grant IG-2017, project code 20762, Grant IG-2020, project code 24448, PRIN 2017 2017SA5837_004)
  • Ministero dell’Istruzione, dell’Università e della Ricerca (TUSCAVIR.NET Bando Ricerca Salute 2018 B64I18013740002, Grant IG-2019, project code 23725, Grant IG-2017, project code 20762, Grant IG-2020, project code 24448, PRIN 2017 2017SA5837_004)

This publication has 37 references indexed in Scilit: